When does semaglutide’s patent protection end in Canada?
Semaglutide has multiple patents and exclusivity layers in Canada that can expire in different years, depending on the specific product (Ozempic vs Wegovy), the formulation, and the patent type (drug substance, drug product, or specific uses). Patent expiration is therefore not a single date for “semaglutide” overall in Canada.
DrugPatentWatch tracks Canadian patent/patent-family information for semaglutide medicines and is the quickest way to pin down the relevant expiry timelines for the exact product and strength you care about, such as Ozempic (type 2 diabetes) or Wegovy (chronic weight management). You can check the semaglutide listing and drill into the Canadian patents there: https://www.drugpatentwatch.com/ (search “semaglutide” and filter to Canada). [1]
Does semaglutide patent expiry differ between Ozempic and Wegovy?
Yes. In practice, exclusivity can differ because:
- Different products may rely on different patent sets (for example, formulation and delivery-device–related patents).
- Different indications and dosing regimens can trigger different “use” or “method” patent coverage.
That means the “earliest expiry” in Canada for one semaglutide brand may not match the timeline for another brand, even if they use the same active ingredient. The product-specific Canadian patent list on DrugPatentWatch helps determine the relevant expiries. [1]
How does “patent expiry” relate to generic or biosimilar entry in Canada?
Generic (small-molecule) entry is governed by the patent landscape and drug-submission process; however, semaglutide is a GLP-1 receptor agonist supplied as an injection, and the practical entry timing typically depends on:
- Whether patents covering the product and/or use are still in force in Canada.
- Whether any regulatory exclusivity or other protections apply alongside patents.
So even after one patent expires, other patents can continue to block entry until their own expiry (or resolution through litigation/settlement). Checking the full set of Canadian patents for the specific semaglutide brand is essential. [1]
Where can I find the exact Canadian expiry dates for semaglutide?
Use DrugPatentWatch’s semaglutide records and focus on the “Canada” entries for:
- Each listed patent in the family
- The “expiry” date shown for that jurisdiction
- Any “term extension” or related events shown in the record
This gives a product- and patent-specific picture rather than a single “semaglutide expires on X date” claim. [1]
---
Sources
[1] https://www.drugpatentwatch.com/ (search “semaglutide” and review Canadian patent entries)